Description
LAB TESTING
First action · last action
2011-02-01 · 2011-02-01
Transactions
1
First transaction's obligation
$35,000
Base + all options value (sum of deltas)
$35,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P7302A
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-02-01+$35,000= $35,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-02-01 | +$35,000 | $35,000 | LAB TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N4EWM4KT4PH7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226P1103 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $150,543 | FY2026 |
| 36C26225P1495 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $267,669 | FY2025 |
| 36C26224P1609 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $188,241 | FY2024 |
| 36C26223P1691 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $129,599 | FY2023 |
| 36C26222P1492 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $173,273 | FY2022 |
| 36F79721D0224 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2021 |
Other recipients under Q301 from 644-PHOENIX (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25813J0076 | AMARILLO PATHOLOGY GROUP L.L.P. | 644-PHOENIX | $169,692 | FY2013 |
| VA25812P0258 | GENOMIC HEALTH, INC. | 644-PHOENIX | $4,175 | FY2012 |
| VA644C11133 | GENOMIC HEALTH, INC. | 644-PHOENIX | $16,300 | FY2011 |
| VA644C11057 | GENOMIC HEALTH, INC. | 644-PHOENIX | $4,075 | FY2011 |
| VA258P0506 | GENZYME CORPORATION | 644-PHOENIX | $238,000 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA644C10187_3600_V797P7302A_3600 · retrieved 2026-09-26.